FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387241348> ?p ?o ?g. }

• W4387241348 abstract "Importance Modulation of intestinal microbiome by administering probiotics, prebiotics, or both may prevent morbidity and mortality in premature infants. Objective To assess the comparative effectiveness of alternative prophylactic strategies through a network meta-analysis (NMA) of randomized clinical trials. Data Sources MEDLINE, EMBASE, Science Citation Index Expanded, CINAHL, Scopus, Cochrane CENTRAL, and Google Scholar from inception until May 10, 2023. Study Selection Eligible trials tested probiotics, prebiotics, lactoferrin, and combination products for prevention of morbidity or mortality in preterm infants. Data Extraction and Synthesis A frequentist random-effects model was used for the NMA, and the certainty of evidence and inferences regarding relative effectiveness were assessed using the GRADE approach. Main Outcomes and Measures All-cause mortality, severe necrotizing enterocolitis, culture-proven sepsis, feeding intolerance, time to reach full enteral feeding, and duration of hospitalization. Results A total of 106 trials involving 25 840 preterm infants were included. Only multiple-strain probiotics were associated with reduced all-cause mortality compared with placebo (risk ratio [RR], 0.69; 95% CI, 0.56 to 0.86; risk difference [RD], −1.7%; 95% CI, −2.4% to −0.8%). Multiple-strain probiotics alone (vs placebo: RR, 0.38; 95% CI, 0.30 to 0.50; RD, −3.7%; 95% CI, −4.1% to −2.9%) or in combination with oligosaccharides (vs placebo: RR, 0.13; 95% CI, 0.05 to 0.37; RD, −5.1%; 95% CI, −5.6% to −3.7%) were among the most effective interventions reducing severe necrotizing enterocolitis. Single-strain probiotics in combination with lactoferrin (vs placebo RR, 0.33; 95% CI, 0.14 to 0.78; RD, −10.7%; 95% CI, −13.7% to −3.5%) were the most effective intervention for reducing sepsis. Multiple-strain probiotics alone (RR, 0.61; 95% CI, 0.46 to 0.80; RD, −10.0%; 95% CI, −13.9% to −5.1%) or in combination with oligosaccharides (RR, 0.45; 95% CI, 0.29 to 0.67; RD, −14.1%; 95% CI, −18.3% to −8.5%) and single-strain probiotics (RR, 0.61; 95% CI, 0.51 to 0.72; RD, −10.0%; 95% CI, −12.6% to −7.2%) proved of best effectiveness in reduction of feeding intolerance vs placebo. Single-strain probiotics (MD, −1.94 days; 95% CI, −2.96 to −0.92) and multistrain probiotics (MD, −2.03 days; 95% CI, −3.04 to −1.02) proved the most effective in reducing the time to reach full enteral feeding compared with placebo. Only single-strain and multistrain probiotics were associated with greater effectiveness compared with placebo in reducing duration of hospitalization (MD, −3.31 days; 95% CI, −5.05 to −1.58; and MD, −2.20 days; 95% CI, −4.08 to −0.31, respectively). Conclusions and Relevance In this systematic review and NMA, moderate- to high-certainty evidence demonstrated an association between multistrain probiotics and reduction in all-cause mortality; these interventions were also associated with the best effectiveness for other key outcomes. Combination products, including single- and multiple-strain probiotics combined with prebiotics or lactoferrin, were associated with the largest reduction in morbidity and mortality." @default.
• W4387241348 created "2023-10-03" @default.
• W4387241348 creator A5008045102 @default.
• W4387241348 creator A5010577087 @default.
• W4387241348 creator A5013315390 @default.
• W4387241348 creator A5015206545 @default.
• W4387241348 creator A5015600263 @default.
• W4387241348 creator A5021317150 @default.
• W4387241348 creator A5027743498 @default.
• W4387241348 creator A5030726218 @default.
• W4387241348 creator A5031717153 @default.
• W4387241348 creator A5031799727 @default.
• W4387241348 creator A5032831621 @default.
• W4387241348 creator A5038341180 @default.
• W4387241348 creator A5038761760 @default.
• W4387241348 creator A5041966023 @default.
• W4387241348 creator A5053676002 @default.
• W4387241348 creator A5061319118 @default.
• W4387241348 creator A5064459641 @default.
• W4387241348 creator A5070327169 @default.
• W4387241348 date "2023-10-02" @default.
• W4387241348 modified "2023-10-12" @default.
• W4387241348 title "Probiotics, Prebiotics, Lactoferrin, and Combination Products for Prevention of Mortality and Morbidity in Preterm Infants" @default.
• W4387241348 cites W1617328014 @default.
• W4387241348 cites W1964227923 @default.
• W4387241348 cites W1971895240 @default.
• W4387241348 cites W1980210906 @default.
• W4387241348 cites W1982160396 @default.
• W4387241348 cites W2007807635 @default.
• W4387241348 cites W2019549525 @default.
• W4387241348 cites W2027617880 @default.
• W4387241348 cites W2037593179 @default.
• W4387241348 cites W2046860342 @default.
• W4387241348 cites W2059459105 @default.
• W4387241348 cites W2063834162 @default.
• W4387241348 cites W2073590621 @default.
• W4387241348 cites W2085803274 @default.
• W4387241348 cites W2091808438 @default.
• W4387241348 cites W2098101414 @default.
• W4387241348 cites W2098923148 @default.
• W4387241348 cites W2125435699 @default.
• W4387241348 cites W2143034146 @default.
• W4387241348 cites W2152730817 @default.
• W4387241348 cites W2155798268 @default.
• W4387241348 cites W2157991180 @default.
• W4387241348 cites W2161931936 @default.
• W4387241348 cites W2165010366 @default.
• W4387241348 cites W2166949225 @default.
• W4387241348 cites W2169677770 @default.
• W4387241348 cites W2185956626 @default.
• W4387241348 cites W2286104098 @default.
• W4387241348 cites W2286344981 @default.
• W4387241348 cites W2301034803 @default.
• W4387241348 cites W2302933368 @default.
• W4387241348 cites W2321143959 @default.
• W4387241348 cites W2462980687 @default.
• W4387241348 cites W2519993310 @default.
• W4387241348 cites W2528175253 @default.
• W4387241348 cites W2553969814 @default.
• W4387241348 cites W2565941527 @default.
• W4387241348 cites W2587656711 @default.
• W4387241348 cites W2588681363 @default.
• W4387241348 cites W2739899008 @default.
• W4387241348 cites W2744957625 @default.
• W4387241348 cites W2766211624 @default.
• W4387241348 cites W2782629792 @default.
• W4387241348 cites W2793807463 @default.
• W4387241348 cites W2891266048 @default.
• W4387241348 cites W3037711410 @default.
• W4387241348 cites W3056082644 @default.
• W4387241348 cites W3099906708 @default.
• W4387241348 cites W3120505215 @default.
• W4387241348 cites W3152804121 @default.
• W4387241348 cites W4210999361 @default.
• W4387241348 cites W4237614629 @default.
• W4387241348 cites W4245773446 @default.
• W4387241348 cites W4281725730 @default.
• W4387241348 cites W4283587010 @default.
• W4387241348 cites W4323285417 @default.
• W4387241348 doi "https://doi.org/10.1001/jamapediatrics.2023.3849" @default.
• W4387241348 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37782505" @default.
• W4387241348 hasPublicationYear "2023" @default.
• W4387241348 type Work @default.
• W4387241348 citedByCount "0" @default.
• W4387241348 crossrefType "journal-article" @default.
• W4387241348 hasAuthorship W4387241348A5008045102 @default.
• W4387241348 hasAuthorship W4387241348A5010577087 @default.
• W4387241348 hasAuthorship W4387241348A5013315390 @default.
• W4387241348 hasAuthorship W4387241348A5015206545 @default.
• W4387241348 hasAuthorship W4387241348A5015600263 @default.
• W4387241348 hasAuthorship W4387241348A5021317150 @default.
• W4387241348 hasAuthorship W4387241348A5027743498 @default.
• W4387241348 hasAuthorship W4387241348A5030726218 @default.
• W4387241348 hasAuthorship W4387241348A5031717153 @default.
• W4387241348 hasAuthorship W4387241348A5031799727 @default.
• W4387241348 hasAuthorship W4387241348A5032831621 @default.
• W4387241348 hasAuthorship W4387241348A5038341180 @default.
• W4387241348 hasAuthorship W4387241348A5038761760 @default.
• W4387241348 hasAuthorship W4387241348A5041966023 @default.
• W4387241348 hasAuthorship W4387241348A5053676002 @default.

• next